Mushrooms, Inc. is a development stage company, which acquires and builds a portfolio of cannabis markets. The company is headquartered in Estero, Florida. The company went IPO on 2006-11-17. The company is engaged in the biotechnology and sustainable healthcare solutions using mushrooms and mycelium. The firm is focused on the industrial application of mycelium for the creation of carbon-neutral products for the building and health care industries, as well as creating supplements based on the proven health benefits of mushrooms. Mycelium is a natural fiber that can be used as an alternative to plastics. Mycelium can be used in applications such as insulation, structural insulating panels, acoustical tiles, and building blocks. The company is improving the threads and fabrics in use with its antimicrobial, anti-MRSA, renewable and eco-positive threads and fabric solutions. The company also works together with scientists and medical supply innovators to implement this technology into the range of potential medical applications.
Follow-Up Questions
What is Mushrooms Inc (MSRM)'s P/E Ratio?
The P/E ratio of Mushrooms Inc is N/A
Who is the CEO of Mushrooms Inc?
Mr. Patrick Montalban is the Chief Executive Officer of Mushrooms Inc, joining the firm since 2002.
What is the price performance of MSRM stock?
The current price of MSRM is 0.0229, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Mushrooms Inc?
Mushrooms Inc belongs to N/A industry and the sector is N/A
What is Mushrooms Inc market cap?
Mushrooms Inc's current market cap is $903.1
Is Mushrooms Inc a buy, sell, or hold?
According to wall street analysts, 0 analysts have made analyst ratings for Mushrooms Inc, including 0 strong buy, 0 buy, 0 hold, 0 sell, and 0 strong sell
